The anti-carbamylated protein antibody response is of overall low avidity despite extensive isotype switching

Rheumatology
Myrthe A M van DelftLeendert A Trouw

Abstract

To better understand the contribution of autoantibodies in RA and the biology of their responses, we evaluated the avidity of the anti-carbamylated protein (anti-CarP) antibody response. The avidity of anti-CarP antibody, ACPA and anti-tetanus toxoid IgG were determined using elution assays. Anti-CarP IgG avidity was measured in sera of 107 RA patients, 15 paired SF and serum samples and 8 serially sampled sera before and after disease onset. The avidity of anti-CarP IgG is low compared with the avidity of anti-tetanus toxoid IgG present in the same sera. Likewise, although less pronounced, anti-CarP also displayed a lower avidity as compared with the avidity of ACPA IgG. No difference in anti-CarP IgG avidity is observed between ACPA positive or ACPA negative patients. Anti-CarP IgG avidity is higher in anti-CarP IgM-negative compared with IgM-positive individuals. Furthermore, the anti-CarP avidity in serum is higher than in SF. Using samples of individuals that over time developed RA we observed no anti-CarP avidity maturation in the years before disease onset. In contrast to ACPA avidity, the anti-CarP avidity is not associated with severity of joint destruction. The anti-CarP response is of overall low avidity, even lower ...Continue Reading

References

Dec 12, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mijke A BreukelsGer T Rijkers
Oct 15, 2003·Arthritis and Rheumatism·Solbritt Rantapää-DahlqvistWalther J van Venrooij
Oct 14, 2004·Annals of the Rheumatic Diseases·S CucnikB Bozic
Feb 26, 2005·Clinical and Experimental Immunology·S Chapuy-RegaudG Serre
May 18, 2007·Journal of Clinical Laboratory Analysis·C T PercianiM M Tanizaki
May 5, 2010·Annals of the Rheumatic Diseases·Diane van der WoudeRené E M Toes
Jul 14, 2010·Annals of Internal Medicine·Tom W J Huizinga, Theodore Pincus
Jul 20, 2010·Rheumatology·Diederik P C de RooyAnnette H M van der Helm-van Mil
Sep 28, 2010·Lancet·David L ScottTom W J Huizinga
Jul 16, 2011·Molecular Immunology·Nina A DahaLeendert A Trouw
Oct 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jing ShiLeendert A Trouw
Dec 2, 2011·Arthritis and Rheumatism·P SuwannalaiL A Trouw
Jan 22, 2013·Nature Immunology·Carola G Vinuesa, Pheh-Ping Chang
Feb 22, 2013·Scandinavian Journal of Rheumatology·R KnevelA H M van der Helm-van Mil
Dec 18, 2013·Annals of the Rheumatic Diseases·Jing ShiLeendert A Trouw
Jul 17, 2015·Rheumatology·Marije K VerheulShunichi Shiozawa
Mar 10, 2017·Nature Reviews. Rheumatology·Leendert A TrouwRene E M Toes
Aug 16, 2017·Arthritis Research & Therapy·Myrthe A M van DelftLeendert A Trouw

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.